Table 3.
AGE | |||
---|---|---|---|
CEL (ng/mL) |
CML (ng/mL) |
MG-H1 (ng/mL) |
|
T2DM (n = 15) | 15.4 ± 6.6 | 21.0 ± 7.0 | 27.2 ± 20.7 |
Non-DM (n = 20) | 9.8 ± 2.2 | 15.1 ± 4.2 | 17.5 ± 8.2 |
P value | <0.001 | <0.01 | NS |
Data are mean ± standard deviation. AGEs: advanced glycation end products; CEL: carboxyethyllysine; CML: carboxymethyllysine; MG-H1: methyl-glyoxal-hydro-imidazolone; T2DM: study participants with type 2 diabetes mellitus; Non-DM: nondiabetic study participants; NS: not significant.